Genomics

Dataset Information

0

Alteration of treatment of the ALK inhibitor in ALK-amplified neuroblastoma


ABSTRACT: Anaplastic Lymphoma Kinase (ALK) most frequently mutated in neuroblastoma (NB) and is atractive molecular target for therapy. However, efficacy of the ALK inhibitor against ALK-amplified NB is unclear. To elucidate genetic alterations induced by treatment of the ALK inhibitor, we compared expression profile between ALK inhibitor-treated and DMSO-treated NB39nu cells using Agilent SurePrint G3 Human GE 8x60K V2 Microarray Kit

ORGANISM(S): Homo sapiens

PROVIDER: GSE107354 | GEO | 2017/11/28

SECONDARY ACCESSION(S): PRJNA419884

REPOSITORIES: GEO

Similar Datasets

2015-05-04 | E-MTAB-3207 | biostudies-arrayexpress
2014-05-28 | GSE57764 | GEO
2016-08-23 | GSE72344 | GEO
2015-05-04 | E-MTAB-3206 | biostudies-arrayexpress
2021-03-26 | GSE112429 | GEO
2015-06-01 | GSE45413 | GEO
2017-04-30 | GSE86652 | GEO
2015-01-01 | GSE52683 | GEO
2015-01-01 | GSE52684 | GEO
2015-01-01 | GSE52682 | GEO